BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31737505)

  • 21. Statins and protein prenylation in cancer cell biology and therapy.
    Garcia-Ruiz C; Morales A; Fernandez-Checa JC
    Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
    Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
    Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins are potential anticancerous agents (review).
    Altwairgi AK
    Oncol Rep; 2015 Mar; 33(3):1019-39. PubMed ID: 25607255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
    Kotamraju S; Williams CL; Kalyanaraman B
    Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance.
    Zaky MY; Fan C; Zhang H; Sun XF
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statins and mitochondria].
    Broniarek I; Jarmuszkiewicz W
    Postepy Biochem; 2016; 62(2):77-84. PubMed ID: 28132458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antitumor effects of statins (Review).
    Jakobisiak M; Golab J
    Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
    Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
    Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
    Martin G; Duez H; Blanquart C; Berezowski V; Poulain P; Fruchart JC; Najib-Fruchart J; Glineur C; Staels B
    J Clin Invest; 2001 Jun; 107(11):1423-32. PubMed ID: 11390424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
    Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence.
    Zeybek B; Costantine M; Kilic GS; Borahay MA
    Reprod Sci; 2018 Jun; 25(6):802-817. PubMed ID: 29320955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells.
    Maeda A; Yano T; Itoh Y; Kakumori M; Kubota T; Egashira N; Oishi R
    Atherosclerosis; 2010 Jan; 208(1):112-8. PubMed ID: 19683239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of statins on breast cancer recurrence and mortality: a review.
    Van Wyhe RD; Rahal OM; Woodward WA
    Breast Cancer (Dove Med Press); 2017; 9():559-565. PubMed ID: 29238220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three's company: regulation of cell fate by statins.
    Vamvakopoulos JE
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):145-63. PubMed ID: 15853756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel applications of statins for bone regeneration.
    Shah SR; Werlang CA; Kasper FK; Mikos AG
    Natl Sci Rev; 2015 Mar; 2(1):85-99. PubMed ID: 26543666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Statin Therapy on the Survival of Patients with Gastrointestinal Cancer.
    Gachpazan M; Kashani H; Khazaei M; Hassanian SM; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(7):738-747. PubMed ID: 30539694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
    Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
    Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.